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The bovine milk microbiota: insights and
perspectives from -omics studies
M. F. Addis,*a A. Tanca,a S. Uzzau,ab G. Oikonomou,c R. C. Bicalhod and P. Moronide
Recent significant progress in culture-independent techniques, together with the parallel development of
-omics technologies and data analysis capabilities, have led to a new perception of the milk microbiota as
a complex microbial community with great diversity and multifaceted biological roles, living in an
environment that was until recently believed to be sterile. In this review, we summarize and discuss the
latest findings on the milk microbiota in dairy cows, with a focus on the role it plays in bovine physiology
and health. Following an introduction on microbial communities and the importance of their study, we
present an overview of the -omics methods currently available for their characterization, and outline the
potential oﬀered by a systems biology approach encompassing metatranscriptomics, metaproteomics, and
metametabolomics. Then, we review the recent discoveries on the dairy cow milk microbiome enabled by
the application of -omics approaches. Learning from studies in humans and in the mouse model, and
after a description of the endogenous route hypothesis, we discuss the role of the milk microbiota in the
physiology and health of both the mother and the oﬀspring, and report how it can be changed by farming
practices and during infection. In conclusion, we shortly outline the impact of the milk microbiota on the
quality of milk and of dairy products.
Microbial communities and the milk
microbiota
The complex living entities defined as microbial communities,
or microbial consortia, have gained increasing interest in
recent years, and the evolution of advanced molecular methods
has spurred a significant wave of studies dedicated to their
detailed understanding. Learning from these studies, we have
now become aware that animals host a wide diversity of
microbial communities that have evolved with them as a result
of complex and mutualistic interactions, and that they play
crucial roles in their biology and health status.1,2 The paradigm
of a highly evolved, complex, and tightly host-interconnected
microbial community is the gastrointestinal microbiota,3–6 but
in recent years the microbial communities of diverse anatomical
sites have been characterized, ranging from more obvious sites
such as the skin and the genitourinary tract, to less obvious ones
such as the airways, and including areas that were previously
considered to be absolutely devoid of microorganisms, such as
the placenta and the fetus.7,8 Until recently, the mammary
gland and the milk contained in it were also believed to be
sterile,9 and microorganisms found in milk were thought to be
the result of an external contamination. However, this belief
has recently been challenged, as a result of the integration of
culture-based methods with more sensitive molecular methods.10
Due to its importance for animal health and its correlations
with the quality and safety of dairy production, the interest in
understanding the origin and composition of the milk micro-
biota has significantly grown in the last decade.11 As a result of
the rapid evolution of meta-omics sciences, a wide range of
approaches is now available for its detailed characterization,
enabling to gather information ranging from its taxonomic
composition to its functional potential and the molecules it
produces as a result of its functioning (Fig. 1).
Approaches to understanding the milk
microbiota: 16S metagenomics and
shotgun metagenomics
The characterization of the whole set of microbial genomes, the
metagenome, might be based on target sequencing of 16S rDNA
or supported by shotgun, genome wide, sequencing. The former
approach relies on a combination of PCR amplification and
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sequencing of a 16S rRNA gene fragment (16S metagenomics).12,13
Therefore, it allows the characterization of the bacterial component
in the microbial community. The rRNA genes are the most
conserved genes in all bacteria, yet they carry hypervariable regions,
where sequences have diverged over evolutionary time. In 16S rDNA
sequencing studies, a pair of so-called ‘‘universal’’ primers is
designed to bind to conserved regions and amplify variable regions
that capture the taxonomic information. Sequencing of the
amplified pool of 16S rDNA fragments enables the most accurate
assignment of each read to its specific taxon. Then, the relative
abundance of each taxon can be estimated.14
However, amplicon-based metagenomics suﬀers from several
limitations, including the loss of diversity due to PCR biases15–18
and variability in diversity estimates.19 For instance, different
16S rDNA variable loci have differential capacity in resolution of
taxa, and the number of 16S rRNA gene copies in bacterial
genomes varies quite considerably. In addition, amplicon
sequencing gives information on the taxonomy of the community,
but not on its biological functions.19–21 Although phylogenetic
reconstruction may provide hints about this latter aspect,22 its
accuracy is linked to the correct representation of the microbial
diversity in the genome sequence databases and is hampered by
the functional gene heterogeneity between strains of the same
species due to horizontal gene transfer.23
To extend the information captured by 16S metagenomics,
shotgun metagenomics provides a further approach to study
the non-culturable microbiota, oﬀering a wider perspective on
microbial diversity.17 In this case, instead of amplifying a
specific target locus, the whole metagenomic DNA is extracted,
reduced into fragments, and sequenced. This produces a great
number of genomic sequences that align to genomic locations
in all the DNA genomes of the whole community, including
DNA viruses and yeasts. As a result, it becomes possible to
interrogate these data either by sampling taxonomically infor-
mative loci, such as 16S rDNA, or by analyzing those sequences
that provide information on the functional potential of the
metagenome, that is, understanding who is in the community,
but also what the community is capable of doing. Interestingly,
the metagenome of a complex microbial community (e.g. human
feces) has been reported to be linearly correlated with the
metatranscriptome, indicating that the measured potential and
actual activity of the microbiota share many similarities.24
Of course, this huge potential brings several challenges.17,25–29
The first and most obvious one is represented by the extreme
complexity and dimension of the data generated. Since a
metagenome is a collection of genomes highly diverse in
abundance, less represented genomes may be only partially
sequenced, and difficulties often arise in obtaining extended
sequences assembly and alignment.30 The vast amount of data
generated, then, needs to be interrogated in order to obtain
meaningful results. This presents problems both in terms of
computational power and in terms of dedicated informatics
software for analysis and interpretation of results. In addition,
unwanted host DNA may be present, often in significant
amounts, requiring the application of molecular and bioinformatics
methods for its removal.31–33 A wide and constantly evolving
range of bioinformatics tools for taxonomy and functional
analysis is available in free software platforms, such as mothur,
QIIME, and UniFrac for 16S, MGRAST, Kraken, and MEGAN for
metagenomics, and LEfSe for differential analysis. Statistical
analysis can then be carried out using software packages such
as R, Metastats, or Primer-E.17,29,34
As a final consideration, generating metagenomic data is
relatively more expensive than shotgun metagenomics, although
the rapid progress in DNA sequencing technologies is improving
this aspect. Several diﬀerent platforms are available.35 Pyro-
sequencing with the Roche/454 GS-FLX is a reliable system that
provides long reads (500 bp), but newer NGS platforms, such as
Illumina HiSeq and MiSeq and Life Technologies Ion Torrent,
have elevated sequencing potential. In bacterial microbiota
Fig. 1 Outline of the approaches available for studying the milk microbiota.
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studies, the HiSeq can provide the highest data output with the
lowest costs, but MiSeq is preferable when short turn-around
times are desired.36,37 The Ion Torrent (Ion PGMt Sequencer and
Ion Protont Sequencer) is also a valid low-cost, scalable and high-
throughput alternative, providing up to 400 bp sequence reads.38
To date, high-throughput sequencing has not been extensively
applied to assess the ruminant milk microbiota, but that will likely
change significantly in the years to come.11,39–41
Beyond metagenomics:
metatranscriptomics, metaproteomics,
and metametabolomics methods
As stated above, the genomic content of a microbial community
gives insights into its functional potential, but no information
can be inferred about the functional activities that the micro-
biota is actually accomplishing under a particular condition or
at a particular time point. To reach this goal, additional -omics
data should be collected from the microbial community by
means of metatranscriptomics, metaproteomics and metameta-
bolomics (Fig. 1 and Table 1).42
Metatranscriptomics analyzes the RNA transcript pool
expressed by a microbial community at a specific point in time,43
thus allowing a simultaneous investigation of the gene expression
(mRNA) and abundance (rRNA) of microorganisms.44 When 16S
rDNA data are already available or not necessary, several strategies
can be applied to enrich for prokaryotic mRNA molecules and
reduce the rRNA fraction of metatranscriptomes,45 such as
selective nuclease degradation of rRNA,46 rRNA depletion by
capture using commercial kits,47 and polyadenylation and
enrichment of mRNA.48 After extraction, RNA is subjected to
reverse transcription to cDNA, and cDNAs are analyzed by high-
throughput sequencing technologies (RNA-seq).49,50 Quality
assessment and decontamination from host/rRNA sequences
can be performed using standard metagenomics tools. Sample
preparation issues due to the low stability of RNA and bioinformatics
issues related to sequence reconstruction, annotation and statistical
analysis can be considered as the main challenging aspects in a
metatranscriptomics investigation.51
Metaproteomics encompasses the large-scale study of the
whole protein complement of a microbiota, providing a direct
measure of the functional activity of a microbial community.13,43
(Meta)proteomics approaches also enable the analysis of splicing
variants and co- and post-translational modifications, as well
as the detection of protein–protein interactions and protein
complexes.52 The analytical requirements for metaproteome
characterization include high sensitivity and a broad dynamic
range of peptide identification.53 In view of this, coupling
effective liquid chromatography (LC) separation systems with
high-resolution mass spectrometers (MS) represents the state-
of-the-art technique for metaproteomics.54 In a typical meta-
proteomics experiment, the extracted proteins are therefore
digested with proteolytic enzyme(s) to generate a complex
peptide mixture, which is eventually analyzed by LC-MS. The
presence of contaminating proteins (e.g. from the host), the
huge dynamic range of protein abundance, and – even more
importantly – the bioinformatics analysis issues (especially
related to the construction and annotation of sequence data-
bases for peptide identification) are the most difficult tasks in
metaproteomics studies.55,56 Notably, the availability of (meta)-
genomic sequences from the community being studied is vital
for efficient protein identification and annotation.57–59
Metametabolomics refers to the systematic analysis of the
metabolite complement produced by microbial communities.
Metabolites are typically in a state of flux, which implies that
their abundance varies as a function of time within the ecosystem.60
The most common analytical techniques used to characterize a
microbial metabolome are MS and proton nuclear magnetic
resonance (NMR), each one with its respective advantages and
disadvantages: NMR is a non-destructive, non-selective and cost-
eﬀective approach, while MS oﬀers better sensitivity and, if
coupled to separation techniques (as LC or gas chromatography),
it is capable of detecting a broader range of molecules.61,62
Specific issues concerning metametabolomics analysis are due
to the non-uniformity of the molecules to be profiled (spanning a
broad range of hydrophobicity and molecular weights) as well as
to the impossibility to directly link the particular metabolite
detected to a specific microbial taxonomy.51,63
The application of a systems biology approach – comprising
metatranscriptomics, metaproteomics and metametabolomics – to
the study of the milk microbiota in the years to come is expected to
provide a much wider and sharper picture of the functional activity
of milk microbial communities, compared to the information that
one would infer from the DNA sequence alone. Each -omics
technology provides a unique perspective, and, by integrating these
Table 1 Features of the -omics approaches available for studying microbial communities
Approach Target molecule(s) Information provided Drawbacks
16S metagenomics 16S rRNA gene (or its hypervariable
regions)
Taxonomic distribution Only bacteria are characterized
Metagenomics Community DNA Taxonomic distribution and
gene potential
Issues with sequence annotation and
costs
Metatranscriptomics Community RNA (or mRNA) Taxonomic distribution and
gene expression
Issues with RNA stability and data
analysis
Metaproteomics Community proteins Taxonomic distribution and
protein expression
Issues with protein dynamic range
and data analysis
Metametabolomics Community metabolites/organic
compounds
Metabolic fluxes No direct link between metabolite
and microbial taxonomy
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large-scale datasets, scientists can investigate microbial community
dynamics and interactions at an unprecedented level (Table 1).64
The healthy milk microbiota
Milk is a complex, species-specific biological fluid aimed to satisfy
the nutritional requirements of the mammalian oﬀspring,
but it also plays numerous functional roles along oﬀspring
development.2,65–67 The biological actions of milk are due to
the presence of immune cells and of an assortment of active
molecules, including sugars, nucleotides, lipids, immunoglobulins,
antimicrobial proteins, cytokines, and other immunomodulatory
factors.66,68–71 In addition, milk contains a complex and varied
community of bacteria, with an abundance estimated in
approximately 103–104 colony-forming units per milliliter in
human milk.72
The human milk microbiota has been the subject of diﬀerent
studies in recent years, aimed to understand its role in the
physiology and health of both the nursing mother and her
infant.65,66 On the other hand, most studies on the dairy ruminant
microbiota have been carried out with focus on how the microbial
flora of milk changes when it becomes a food product, either for
direct consumption or for transformation into dairy products, that
is, by considering the microbial ecology of raw milk, rather than
how the milk microbiota behaves in the context of animal health
and physiology.11 To date, only few studies have been carried
out in cows with this purpose. Kuehn et al. used pyrosequen-
cing of bacterial 16S rRNA genes to investigate bacterial DNA
diversity in 10 mastitic, culture negative, milk samples.73 In
this work, the microbiota of milk samples obtained from
healthy quarters from the same cows was also described for
comparison purposes. The authors were able to show significant
diﬀerences among the microbial profiles of healthy milk samples.
The most abundant genera were: Ralstonia, Pseudomonas,
Sphingomonas, Stenotrophomonas, Psychrobacter, Bradyrhizobium,
Corynebacterium, Pelomonas, and Staphylococcus. Abundances of
Pseudomonas, Psychrobacter, and Ralstonia were significantly
higher in healthy samples compared to the mastitic ones. In a
more recently published study, Oikonomou et al. described in
detail the microbial diversity of 144 bovine milk samples derived
from clinically unaﬀected quarters across a range of somatic cell
count values.74 Fecalibacterium, unclassified Lachnospiraceae,
Propionibacterium and Aeribacillus were present in all the samples
obtained from healthy quarters, and could be considered part of a
healthy milk core microbiota. Other genera found to be prevalent in
most of the milk samples with very low somatic cell counts were:
Bacteroides, Staphylococcus, Streptococcus, Anaerococcus, Lactobacillus,
Porphyromonas, Comamonas, Fusobacterium and Enterococcus (Fig. 2).
Certain bacterial genera (e.g. Lactobacillus and Paenibacillus) were
associated with healthier udder quarters.
Zhang et al. described the eﬀects of diﬀerent dairy cattle
diets (high concentrate versus low concentrate diet) on milk
microbial communities using pyrosequencing of the 16s rRNA
genes.75 Despite the small number of animals enrolled in their
study (n = 4), the authors were able to suggest diet associated
diﬀerences in milk microbial communities. In the work by
Falentin et al.,76 milk from healthy quarters was associated with a
high proportion of the Clostridia class, the Bacteroidetes phylum
and the Bifidobacteriales order. Table 2 summarizes the current
findings on composition of the healthy cow milk microbiota.
Fig. 2 Distribution of the twenty most prevalent bacterial genera found in
50 healthy quarter milk samples with less than 20000 cells mL1.74
Table 2 Composition of the healthy cow milk microbiota
Study Most prevalent genera
Kuehn et al.73 Ralstonia, Pseudomonas, Sphingomonas,
Stenotrophomonas, Psychrobacter, Bradyrhizobium,
Corynebacterium, Pelomonas, Staphylococcus
Oikonomou et al.77 Propionibacterium, Aeribacillus, unclassified
Lachnospiraceae, Faecalibacterium, Bacteroides,
unclassified Clostridiales, Staphylococcus,
Streptococcus, Anaerococcus, unclassified
Xanthomonadaceae, unclassified Bacteroidales,
unclassified Bacteria, Lactobacillus, Porphyromonas,
Comamonas, Fusobacterium, Enterococcus,
unclassified Carnobacteriaceae, Asticcacaulis
Zhang et al.75 Chryseobacterium, Streptococcus, Enterococcus,
Stenotrophomonas, Brevundimonas, Lactococcus,
Sphingomonas, Prevotella, Sphingobacterium,
Helcococcus, Leucobacter, Butyrivibrio, Atopostipes,
Bosea, Alcaligenes, Ruminococcus, Facklamia,
Actinomyces, Sphingobium, Trueperella,
Pseudomonas, Enterobacter, Comamonas,
Megasphaera, Salinicoccus, Ochrobactrum,
Lactobacillus, Mogibacterium, Peptococcus,
Succiniclasticum, Myroides
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In dairy ruminant species other than cows, studies have
been carried out almost exclusively for the purpose of dairy
production, and not for investigating mammary health or oﬀ-
spring health. Therefore, experimental design and sampling
procedures may not be adequate for extracting information on
the sensu stricto milk microbiota.11
Origin of the milk microbiota: the
endogenous route hypothesis
Traditionally, it is believed that bacteria found in milk result
from contamination by the external environment, the mammary
gland skin, or the oral cavity of the oﬀspring. However, several
studies support the hypothesis that the presence of bacteria in
milk is not the mere result of external colonization. It has been
demonstrated that, in addition to their diﬀerent composition in
terms of bacterial taxa, bacterial isolates present in the mammary
gland are genotypically diﬀerent from those found in skin, within
the same host and the same bacterial species.78 Therefore, the
udder skin and teat canal cannot be considered as the sole
contributors to shaping the milk microbiota.65,79 In addition to
this, bacteria such as bifidobacteria are strictly anaerobic,
making skin an unlikely source.80 These and other observations
have led to consider the possibility of an endogenous route. In
fact, ecological niches in the host microbiota do not constitute
separate environments, but are rather a network of inter-related
communities undergoing constant exchanges.81 Therefore,
microorganisms from other anatomical locations may in some
way enter the mammary gland. More specifically, several
authors described the existence of an entero-mammary pathway,
based on the ability of some microbes to leave the intestinal
lumen, travel through the mesenteric lymph nodes, and reach
the mammary gland.65,71,78,82–85
The suggestion of an endogenous origin of the milk microbiota
has been corroborated by diﬀerent studies carried out inmice.71,86–89
Although the mechanisms by which microbes get to cross the
intestinal barrier and reach other body sites have not been com-
pletely clarified, it is likely that these may involve immune cells,
especially dendritic cells (DCs).71,82 In fact, DCs are able to sample
intestinal contents by opening the tight junctions among entero-
cytes, and reach the lumen with their dendrites without damaging
the epithelial barrier integrity.85,90 As a result of this sampling ability,
these cells can harbor live commensal bacteria, and carry them to
the mesenteric lymph nodes.91,92 Once there, bacteria remain viable
for up to several days, and have the chance to spread to other distant
mucosal surfaces, including the lactatingmammary gland, bymeans
of themucosal associated lymphoid system. In fact, during lactation,
cells from gut-associated lymphoid tissue travel to the breast via the
lymphatic and peripheral blood circulations. Donnet-Hughes et al.
showed that, during lactation, human peripheral blood mono-
nuclear cells and breast milk cells contain bacteria and their genetic
material.85 In addition, the presence of viable lactic acid bacteria in
the bloodstream of human subjects has been reported,93–95 further
showing that somemembers of the intestinalmicrobiotamay have a
rather underrated ability to travel to distant extra-intestinal locations
of their host in a viable form.65 The authors also showed an increase
in bacterial translocation from the mouse intestine during preg-
nancy and lactation and the presence of bacterially loaded DCs in
lactating breast tissue.
The hormonal and physiological changes occurring during
late pregnancy and lactation influence and condition permissivity
of this bacterial transport.66 It is believed that, in addition to the
transport of viable members of the intestinal microbiota, this
mechanism has the role of educating the oﬀspring’s immune
system to recognize molecular patterns associated with commensal
microorganisms, in order to develop an appropriate response to
them.85 This migration may occur either selectively, that is, certain
strains may be recognized by immune cells and transported into
milk, while others may not, or immune cells may take up all
microorganisms, but only those able to escape killing would be
transported to the mammary gland.96
A recent article by Young et al. reported the transfer of
intestinal bacteria to the mammary gland in cows, supporting
the existence of an endogenous entero-mammary pathway also
in ruminants.97 The authors have investigated the microbial
composition and diversity of feces, milk leukocytes and blood
leukocytes in healthy lactating cows by pyrosequencing
barcode-tagged 16S rDNA amplicons, demonstrating the shared
presence of a small number of bacterial OTUs belonging to the
Ruminococcus and Bifidobacterium genera and to the Peptostrepto-
coccaceae family in all three samples from the same animals. In
order to avoid external contamination and to prevent stretching or
damaging of the teat canal, the authors used a catheter for
collecting milk by gravity into a sterile container. The presence of
these bacteria in the three environments supports the occurrence
of a mechanism responsible for migration of some components of
the intestinal microbiota to the mammary gland via circulating
Fig. 3 Hypothesis of the entero-mammary pathway in ruminants and the
mother–offspring microbial flow.
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white blood cells. However, the cell types responsible for the
traﬃcking of microbiota from the mesenteric lymph nodes to
milk remain to be established.
Further research will be needed to dissect the mechanisms
by which intestinal bacteria are transported to the circulation
and to the mammary gland of ruminants as well as to under-
stand the implications that this can have for the health of the
lactating animal, her oﬀspring, and the human consumer. The
current knowledge on the entero-mammary pathway hypothesis
in ruminants is outlined in Fig. 3.
Functions of the milk microbiota:
lessons learned from human milk and
the mouse model, and hints about its
impact on the health of the ruminant
oﬀspring
As stated above, most of the studies on the physiological milk
microbiota of dairy ruminants have been carried out with focus
on how the microbial flora of milk evolves when it ceases to
become a sensu stricto biological fluid to become a processed
food or a dairy product.11 Therefore, most of the insights into
the physiology of the mother’s milk microbiota and its influences
on the oﬀspring development and health have been gathered from
studies on humans and on the mouse model.
The milk microbiota exerts many short and long term influences
on the physiology of both the mother and the oﬀspring.71,72,98–101
One of these is the transmission of microbes to the developing
offspring’s gastrointestinal tract (Fig. 3).65,78,80,102–104 The role of the
milk microbiota as a ‘‘seed’’ for the developing intestinal microbiota
is also evident in their close similarity; it is only after weaning that a
significant diversification of the two communities takes
place.105 As an example of the complex interaction among milk
molecules, milk microbiota and offspring intestinal microbiota,
it has been demonstrated that the abundant oligosaccharides
present in human milk (HMOs, human milk oligosaccharides) are
not digestible by the lactating infant. Instead, these are fermented
by specific phylotypes of bifidobacteria and lactobacilli.106–109 In
this way, HMOs provide a selective advantage to the milk and
intestinal microbes that are able to metabolize them, and to thrive
in the acidic environment generated by their digestion. In turn, this
developing, selected microflora acts as a competitive ‘‘guard’’ to the
blooming of adverse microbes. Although at a lower concentration
than human milk, bovine milk does also contain complex milk
oligosaccharides analogous to HMOs, the bovine milk oligo-
saccharides (BMOs).110–113 However, the role that these BMOs
play in the milk microbiota of the cow mammary gland and of
the intestinal microbiota has not been investigated yet.
Milk influences other health promoting bacteria, including
Lactobacillus, Bacteroides, and Clostridium species, that can
influence mucin production, mucosal permeability, T-cell balance,
and dampening of mucosal inflammation.114–119 Studies carried
out in germ-free mice have revealed that the development of a fully
functional immune system requires early life colonization.120
All this considered, milk bacteria can be crucial for programming
the appropriate functionality of the immune system against food
antigens, pathogens, and commensal bacteria. Therefore, the
intestinal microbiota of the offspring and the evolution of its
immunity are shaped by the ‘‘seeding’’ operated by the milk
microbiota derived from the mother’s entero-mammary pathway,
by the infant’s environment, and by the continuous crosstalk
between the mother’s mammary gland and the suckling infant’s
oral microbiota, with their synchronized development and evolu-
tion throughout lactation. In support of this latter observation,
Cabrera-Rubio et al. have demonstrated that the milk microbiota of
healthy women evolves along lactation, and undergoes a series of
changes as lactation proceeds.79
In ruminants, the role of the milk microbiota in shaping the
intestinal microbiota of the newborn takes a further implica-
tion. In fact, these animals harbor an additional, very complex
microbial community, the rumen microbiota, which has the
crucial role of carrying out plant digestion and converting the
otherwise non-digestible material into useful chemical com-
pounds.121 Microbial colonization in the rumen occurs almost
immediately; bacteria with cellulolytic capabilities are already
present in 3–5 day old calves and are abundant in 2–3 week old
calves.122,123 Recently, a study on ruminal bacterial communities
has demonstrated that pre-ruminant calves harbor bacteria and
functions that are present in mature animals.124 By using a
pyrosequencing approach, Jami et al. have demonstrated that
cellulolytic bacterial species are already present in the rumen of
newborn calves as early as 1 day after birth and in increasing
abundance on the third day.121 This is reinforced by Fonty et al.
and Minato et al., who isolated cellulolytic bacteria from the
rumen in the first week after birth.122,123 Jami et al. demon-
strated that the establishment of crucial bacterial species in the
rumen begins on the first day of life, when the animals are still
being fed exclusively colostrum, that is, before the intake of the
plant material.121 This notion has also been advanced for
microbial communities in the developing human infant’s intest-
inal microbiota.125 Although the authors have postulated that
this primary bacterial community might be transmitted from the
mother, they have proposed that this may occur via skin, the
birth canal, or saliva.126 However, the role of the mother’s
entero-mammary pathway in seeding the microbiota of the
young ruminant might deserve further investigation.
The milk microbiota and mammary
gland infection
Mastitis due to intramammary infection is a highly prevalent
disease in dairy cows and it is arguably the most important one
for the dairy industry worldwide, causing economic losses due
to reduced milk production, discarded milk, lower probability
of conception, premature culling, and treatment cost.127 The
decrease in milk production per cow resulting from mastitis
has been well-studied, and is estimated to impact approximately
15% of the milk production potential of the aﬀected cow.128
Mastitis is also a serious animal welfare issue as it is associated
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with pain, reduced well-being and behavioural changes of the
aﬀected animals.129 Defined as inflammation of the mammary
tissue, it can be characterized by the movement of leukocytes
and serum proteins from the blood to the site of infection. As a
consequence, mastitis is typically monitored by using as an
indicator the number of cells present in a milliliter of milk, defined
as the somatic cell count, although novel, potentially highly
sensitive, protein markers are emerging to aid its detection.130–137
Intramammary infection can be categorized into subclinical and
clinical disease; the former is thought to be 3–40 times more
prevalent than the latter and is defined as the presence of infection
without clinical signs of local inflammation, whilst clinical mastitis
involves an inflammatory response causing visibly abnormal
milk, sometimes accompanied by swelling and/or redness of the
mammary glands, and by an increase in the somatic cell count.
Identification of the bacteria responsible for intramammary
infection is an important component of eventual clinical resolution
of the disease. Currently, bacterial culture is the gold standard
method for the identification of mastitis-causing microorganisms.
However, limitations of classical bacterial culture, such as 48 hours
to obtain results, or the fact that in approximately 25% of milk
samples from clinical mastitis cases bacteria are not detected in
conventional culture have spurred investigations of culture
independent, molecular techniques for mastitis diagnosis.138
Methods such as real-time PCR,139 multiplex PCR (mPCR),140
denaturing gradient gel electrophoresis (DGGE) PCR,141 and PCR
single-strand conformation polymorphism (SSCP)142 are now
being used to identify bacterial DNA in milk samples. Molecular
epidemiological studies have greatly contributed in advancing
our knowledge of bovinemastitis and have been extensively used
for over two decades now.143
Bhatt et al. performed metagenomic analysis of milk samples
collected from Kankrej, Gir (Bos indicus) and crossbred cattle
aﬀected with subclinical mastitis using shotgun sequencing
and 454 GS-FLX technology.144 Their metagenomic approach
confirmed the culturing results, but was also able to produce a
significant amount of additional information. A total of 56
diﬀerent species with varying abundance were detected in the
subclinically infected milk together with several bacteriophages.
The authors concluded that subclinical mastitis is a polymicrobial
disease, a conclusion that was not well supported by their data
mainly because samples from unaﬀected quarters were not
obtained for comparison purposes.
Oikonomou et al. used metagenomic pyrosequencing of
bacterial 16S rDNA genes to investigate bacterial DNA diversity
in milk samples of mastitic and healthy dairy cows and
compared the results with those obtained by classical bacterial
culture.145 One hundred and thirty-six milk samples were
collected from cows showing signs of mastitis and used for
microbiological culture. The mastitis pathogens identified by
culture were generally among the most frequent organisms
detected by pyrosequencing, and in some cases (Escherichia coli,
Klebsiella spp. and Streptococcus uberis mastitis) the single most
prevalent microorganism. Trueperella pyogenes sequences were the
second most prevalent sequences in mastitis cases diagnosed as
Trueperella pyogenes by culture, Streptococcus dysgalactiae sequences
were the second most prevalent sequences in mastitis
cases diagnosed as Streptococcus dysgalactiae by culture, and
Staphylococcus aureus sequences were the third most prevalent
in mastitis cases diagnosed as Staphylococcus aureus by culture.
In samples that were aerobic culture negative, pyrosequencing
identified DNA of bacteria that are known to cause mastitis,
DNA of bacteria that are known pathogens but have so far not
been associated with mastitis, and DNA of bacteria that are
currently not known to be pathogens. Additionally, a high
number of anaerobic bacterial sequences (with sequences
belonging to Fusobacterium necrophorum being highly prevalent)
were identified in all mastitis cases, regardless of the culture-
based diagnosis. On the other hand, Fusobacterium necrophorum
sequences were practically absent in the 20 samples that were
derived from healthy, low somatic cell count quarters, while
Porphyromonas spp. sequences were detected but in low prevalence
compared to their prevalence in the mastitic samples. Therefore,
a possible role of certain anaerobic bacteria as opportunistic
pathogens was speculated. This study showed that the meta-
genomic pyrosequencing of 16S rDNA should be considered
an important tool to advance our knowledge regarding the
pathogenesis of bovine mastitis and could be developed as a
diagnostic tool. However, being a cross-sectional prevalence
study, it lacked the ability to show a proper time order to infer
a cause and eﬀect relationship. By using pyrosequencing of
bacterial 16S rDNA genes, Kuehn et al. described the bacterial
communities in culture negative mastitic milk samples, showing
significant diﬀerences with healthy milk samples. Principal
coordinates analysis suggested that non-clinical and clinical
samples generally fell within separate clusters.73 In the study
by Oikonomou et al., in addition to bacterial genera present in all
the samples obtained from healthy quarters (Faecalibacterium,
unclassified Lachnospiraceae, Propionibacterium and Aeribacillus),
Streptococcus uberis sequences were found in all groups of samples,
with a lower prevalence in low somatic cell counts groups. This was
considered unexpected by the authors as this bacterial species is
generally recognized as a major mastitis pathogen. It was hypo-
thesized that Streptococcus uberismay, although in small quantities,
be part of the normal milk microbiota, and therefore clinical
mastitis may in such cases be a dysbiosis, rather than a simple
primary infection.74 In the study by Falentin et al., quarters with a
mastitis history showed a higher proportion of the Bacilli class
(Staphylococcus) and Chlamydia class.76 Concerning dairy ruminant
species other than cows, there are basically no -omics studies on
how the milk microbiota changes in mastitis.
From the studies carried out in women on the role of the
milk microbiota in intramammary infections and mastitis, we
may gather useful hints on the possible role of the intestinal
microbiota as a reservoir for mastitis-causing bacteria. On the
other hand, mechanisms such as nutrient competition, bacteriocins
and antimicrobial molecules released by specific members of
the community in milk may play a role in repressing the
blooming of potential pathogens, thereby preventing intra-
mammary infections.100 Hunt and coworkers have reported
the host-dependence of the milk microbiota in women, and have
suggested that its composition may play a role in determining
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whether they will suﬀer or not from mastitis.72 As reviewed
above, HMOs have the ability to modulate the intestinal microbiota
of the breastfed infant, and structurally analogous oligosaccharides,
BMOs, are present in cow milk.110–113 As such, it can be speculated
that BMOs may also impact bacterial communities of the cow
mammary gland.66 Interestingly, HMOs fall within milk group
categories that mirror blood group characteristics, and are under
genetic control.146 It has been demonstrated that some strains of
Staphylococcus, the leading cause of mastitis in women, bind only to
selected HMO types.147 This would suggest that susceptibility to
mastitis might be conditioned not only by the bacterial composition
of milk or by exposure to specific pathogens, but also by the genetic
makeup of the animal and the corresponding type of BMOs present
in milk.66
The existence of an entero-mammary pathway in ruminants97
(Fig. 3) opens several interesting speculations concerning possible
alternative methods for mastitis treatment using antibiotics. In
women, an eﬀective mastitis treatment has been carried out by the
oral administration of probiotics, including Lactobacillus salivarius
CECT5713 and L. fermentum CECT5716.88,89 These impacted the
milk microbiota by lowering the total bacterial count by 2log and
replacing mastitis-causing Staphylococcus species with Lactobacillus
species. This was also shown to facilitate breastfeeding, leading to
health benefits for both the mother and the infant. The possibility
of influencing the milk microbiota through the oral administration
of pre- or probiotics may open interesting perspectives in reducing
the risk of mastitis in dairy cows.148 These examples emphasize the
possible magnitude of the milk microbiota influence on dairy
ruminant health, demanding future investigations.
The impact of farming practices on the
mother/oﬀspring microbiota crosstalk,
and the waste milk issue
Current farming practices pose several hindrances to the finely
evolved crosstalk between themother and the oﬀspringmicrobiota.
In fact, although calf management procedures can slightly vary
among commercial dairy farms,149 calves are removed from their
dams after birth, and administered colostrum, pooled colostrum,
or colostrum substitutes. Then, they are typically fed whole bulk
tank milk, milk replacer, or a combination of them, together with a
starter feed. Therefore, the mother/oﬀspring microbiota axis, with
its reciprocal crosstalk, is disrupted. In ruminants that are left with
their mothers, the mother/oﬀspring crosstalk may play a relevant
role in the evolution of both the mother’s milk and the intestinal
microbiota of the oﬀspring along lactation.
In dairy calf management, attention should be paid to the
quality of colostrum and milk that are administered in the
farm, when considering that a healthy, well-balanced,
microbiota-competent mother’s milk is crucial for the correct
development of the oﬀspring’s immune system. In fact, an
imbalance in the intestinal microbiota is seen when calves are
under stress conditions, such as in intensive rearing systems,
with a reduction of Lactobacillus and Bifidobacterium species
and an increase in pathobiont microorganisms. It is also
interesting to notice that feeding whole milk to calves improved
the ratio of lactic acid bacteria to coliforms, further demon-
strating the complex action exerted by milk on the intestinal
microbiota.150
Much care is taken to provide clean and high quality
colostrum to newborn calves within 6 hours of birth. However,
numerous farms use unsaleable, waste milk, for post-colostrum
calf feeding. Waste milk is represented by milk which cannot be
sold for human consumption, and it is typically derived from
cows with high somatic cell counts and from cows treated with
antibiotics.151 Feeding waste milk to preweaned calves is a
widespread phenomenon, if one considers that, in 2002, it
was practiced in 87.2% of all US dairy farms.152 The use of
waste milk is economically advantageous for the farmer, and it
is generally believed to be a safe and better alternative to milk
replacers, especially after pasteurization. However, it can raise
some concerns. In fact, waste milk can be heavily unbalanced
in terms of milk microbiota, contaminated with potentially
harmful pathogens,153 or contain antibiotic residues, with
possible consequences on the future animal well-being.154
These issues have been examined by diﬀerent research
groups. Edrington et al. evaluated the eﬀect of feeding waste
milk on the bacterial diversity of the dairy calf fecal micro-
biota.149 The authors applied 16S rDNA bacterial tag-encoded
FLX amplicon pyrosequencing to fecal samples from one week
to six month old dairy calves fed pasteurized or unpasteurized
waste milk. As a result, bacterial diversity in terms of the total
number of diﬀerent species was higher in calves fed pasteurized
waste milk, and increased with age in both groups. Concerning
specific microorganisms, Salmonella was detected in calves
fed unpasteurized waste milk, and Treponema, an important
beneficial bacterium in rumen, was higher in the pasteurized
waste milk group, becoming higher with age in the same group.
The consistent detection of Salmonella only in young calves fed
unpasteurized waste milk was an important finding related to
this practice. In conclusion, therefore, pasteurization of waste
milk was advised. The impact of feeding bulk milk or waste milk
on calf performance and health was also evaluated by Aust and
coworkers. According to these authors as well, pasteurized waste
milk can be considered an acceptable feed.155
A more significant problem concerning the use of waste
milk, however, may be represented by the presence of anti-
microbial residues, and the potential enrichment in the anti-
biotic resistance gene (ARG) pool available for transfer to
pathogens, the ‘‘resistome’’.156 In addition, continuous anti-
biotic pressure may increase opportunities for horizontal ARG
transfer.157–159 It should also be considered that the intestinal
microbiota resistome is largely studied using culture-based or
PCR-based experiments, with a consequent underestimation of
novel resistance genes.160–163
An important aspect that needs to be taken into account
when examining literature data is the administration route. In
this respect, mouse models can provide useful indications for
the impact of antibiotics fed to young calves through waste
milk consumption, since in the case of infant mice antibiotics
are administered through the mother’s milk.154,164 In support
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of this observation, significant diﬀerences were observed upon
oral administration versus intravenous administration of ampicillin
and tetracycline. Oral administration resulted in a 4-log increase in
ampicillin and a 2-fold increase in tetracycline resistance gene copy
number over intravenous administration. This is also probably due
to the fact that intravenously administered ampicillin is cleared
through urine and does not interact with the gut microbiota.165
In addition to enrichment and selection of ARGs, antibiotics can
aﬀect specific phylogenetic subgroups of the intestinal microbiota.
Preterm human infants treated with diﬀerent antibiotics have an
increased load of potentially pathogenic (pathobionts) Entero-
bacteriaceae, and a lower number of Bifidobacteriaceae, Bacilli,
and Lactobacillales that are connected to a healthymicrobiota.166–168
In mice exposed to subtherapeutic doses of antibiotics in drinking
water, there was a significant decrease in the ratio of Bacteroides
to Firmicutes, although this may depend on the specific spectrum
of antibiotics used.164 In another study, the administration of
cefoperazone was associated with a loss in microbial diversity
without recovery at six weeks.169 Therefore, in mice, even low
antibiotic dosages have long-term consequences on micro-
organisms associated with healthy microbiota, including
Lactobacillus spp., Bifidobacteriaceae (lowered) and Entero-
bacteriaceae (increased).164,167
Limited information is currently available on the impact of
drug residues on the microbiota using in vivo natural models.
Van Vleck Pereira et al. evaluated the eﬀect on the calf fecal
microbiota of feeding raw milk spiked with antibiotic concen-
trations below the safe levels limit established by the Federal
Department of Agriculture (FDA).170 Sequencing of the micro-
bial 16S rRNA genes was conducted using the Illumina MiSeq
on calf feces collected along six weeks of age. The study
demonstrated that the presence of drug residues in the milk
aﬀects the composition of the microbial population in the
feces. In fact, the weekly fecal microbial profile of the two calf
groups was easily discriminated at the genus level, although no
significant diﬀerences were seen for higher taxonomic levels.
The authors postulated that even minimal antibiotic concen-
trations may have a selective impact on the competition among
microbes, by influencing the final balance between sensitive
and resistant microbial populations, that is, residues can exert
a selective pressure on immature microbiota that have none or
very low resistance to colonization by foreign microbes, result-
ing in an abrupt transition to a microbial profile that is most
commonly found in older preweaned calves. In fact, when
microbes are exposed to sub-minimal inhibitory concentrations
of antibiotics, these will not kill all susceptible bacteria, but will
impair their growth, providing a selective advantage to
microbes that carry ARG with low fitness costs, contributing
to their persistence even when the antibiotics are removed.171
The occurrence of changes in the fecal microbiota of young
calves upon parenteral antibiotic administration was also seen
by Oultram et al. in a preliminary study.172 One week post
treatment the groups showed the greatest diﬀerence in the fecal
microbiota composition, while two weeks post-treatment they
became more similar, showing a recovery of microbial diversity
in the treated group. Lactobacillus species were the most
aﬀected by antibiosis. Further studies will be needed, and
are advised, to clarify the impact of antibiotic residues in milk
on the correct maturation and health of the dairy ruminant
microbiota.
Another farming practice potentially interfering with the
milk microbiota balance is represented by the intramammary
antibiotic therapy administered to cows at drying-oﬀ or during
lactation. In fact, many dairy herds are routinely treated in
every quarter with antibiotic at drying oﬀ. This is defined as the
‘‘blanket’’ approach, and is considered more eﬀective than
selective treatment in preventing new infections early in the
dry period, without requiring laboratory screening procedures
to decide which cows and quarters to treat. Lactation intra-
mammary antibiotic tubes are the most common treatment for
mild and moderate cases of mastitis, and are usually given
without knowing the type of bacteria that is causing the
infection.173,174 However, when subclinical mastitis in a herd
is very low (every cow has an SCC below 100 000 cells mL1),
intramammary antibiotic administration only to selected
higher risk cows is considered appropriate by some dairy
farmers and veterinarians. Because of concerns about selection
for antimicrobial resistance, the blanket approach has not been
implemented in the Nordic European countries for decades and
it is increasingly abandoned in The Netherlands. The impact of
this practice on the physiological milk microbiota and on the
potential selection for ARG may deserve further investigation.
Raw milk microbial ecology and its
impact on dairy products
Being a rich and nutritious fluid, milk supports the growth
of many microorganisms. Therefore, in addition to its endo-
genous microbiota, once milked it is rapidly colonized by a
variety of other microbes coming from the teat canal, udder
skin, milking machines, containers and tanks used for its
storage, reflecting the farm and the pasture environment as
well. In addition to their contribution to milk fermentation by
transforming lactose in lactate, they can bring about a variety of
attributes that impact the sensory and textural characteristics
of the dairy products derived from milk.175 Furthermore,
contamination with, and subsequent growth of potentially
pathogenic bacteria (or with toxins produced by them) in milk
can have implications for human health and are therefore
relevant issues to consider. And, it is also important to assess
how the composition of the microbiota evolves in raw milk
during milking, transport, storage, and dairy processing, and
how it impacts the composition and quality of dairy products
(Table 3).
These studies have been recently covered in a complete and
extensive review by Quigley and coworkers, and we refer the
readers to their work for a detailed description of the recent
literature on this subject.11 In their review, the authors have
described the current knowledge on the microorganisms
that can be found in raw milk of the main dairy ruminant
species.
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Conclusion
The tremendous evolution of molecular and -omics technologies
has enabled numerous breakthroughs in the study of microbial
communities, making us aware of the varied and complex assort-
ments of microbes that inhabit living animals and the reciprocal
interactions that these entertain among themselves and with their
hosts. Following the unexpected acknowledgement that even the
healthy mammary gland and the milk contained within it are
colonized by a variety of microbes, -omics approaches have already
been used to enable their characterization in humans as well as to
understand the role they play in the health of both the mother and
the oﬀspring. Following the studies on raw milk microbial ecology,
-omics approaches are now beginning to be applied also to the
sensu stricto milk microbiota of dairy ruminants. As a result, its
relevant interactions with the physiology and health of the lactating
dam and the suckling oﬀspring are becoming more and more
evident. Considering the significant economical implications that
this can have for dairy ruminant farming, the application of -omics
sciences to the milk microbiota is expected to improve our under-
standing of open questions and challenges, such as the etiology
and dynamics of sub-clinical and culture-negative mastitis, the
impact of farming management decisions on the health of the
mammary gland and the oﬀspring, the role of the intestine as a
mastitis pathogen reservoir, the development of novel strategies for
preventing and managing mastitis, and the control of antibiotic
resistance.
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